methyl 4-t-butylthiazole-2-carboxylate | 79247-75-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: methyl 4-t-butylthiazole-2-carboxylate
• 英文别名: Methyl 4-tert-butyl-1,3-thiazole-2-carboxylate；methyl 4-tert-butyl-1,3-thiazole-2-carboxylate
• CAS: 79247-75-9
• 化学式: C₉H₁₃NO₂S
• 分子量: 199.274
• InChiKey: CQUCCBMAIIQCLU-UHFFFAOYSA-N

物化性质

• 沸点：
  267.5±33.0 °C(Predicted)
• 密度：
  1.127±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.56
• 拓扑面积：
  67.4
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  1-溴频哪酮 在 氢氧化钾 、 硫酸 、 水 作用下， 以 乙醇 为溶剂， 反应 240.58h， 生成 methyl 4-t-butylthiazole-2-carboxylate
  参考文献：
  名称：

  噻唑-2-羧酸酯的旋转异构现象的红外研究

  摘要：

  制备了一系列在4-和5-位含有一系列取代基的烷基噻唑-2-羧酸酯。这些酯的溶液（大多数是新化合物）在ir C O区域显示出良好拆分的双峰，这是由旋转异构体引起的。较高的波数分量被分配到更多的极性羰基Ø，小号-反-小号-反式-rotamers和下波数分量羰Ø，小号-顺式-小号-反式-forms。注意到甲酯之间的微小但系统的差异。

  DOI：

  10.1039/p19810002335

文献信息

• ARYL HYDROCARBON RECEPTOR MODULATOR
  申请人：Ariagen, Inc.

  公开号：US20190307731A1

  公开（公告）日：2019-10-10

  Disclosed is an aryl hydrocarbon receptor modulator of formula (I), and a pharmaceutically acceptable salt thereof, wherein R′ is H, CN, CH 2 (OH)R 0 , C m H 2m+1 , C n H 2n-1 , C n H 2n-3 , two R a are independently H or two R a together form ═O or ═N—W 3 —R 1 ; A is a C 6 to C 10 aromatic ring unsubstituted or substituted with 1 to 3 R, or a C 2 -C 10 heteroaromatic ring interrupted by 1 to 5 heteroatoms selected from N, O, and S or a 4 to 7 membered nonaromatic heterocyclic ring containing C═N and interrupted by 1 to 3 heteroatoms selected from N, O, and S, with either one unsubstituted or substituted with 1 to 3 R; Q is R, or is a C 6 to C 10 aromatic ring or a C 2 to C 10 heteroaromatic ring unsubstituted or substituted with 1 to 3 R and interrupted by 1 to 5 heteroatoms selected from N, O, and S; and R is R c which is C-attached or R N which is N-attached. The compounds of formula (I) of the present invention can regulate AhR activity, and can be used to inhibit the growth of cancer cells and inhibit the metastasis and invasion of tumor cells.

  本发明揭示了一种化学式（I）的芳香烃受体调节剂及其药用可接受盐，其中R′为H、CN、CH2（OH）R0、CmH2m+1、CnH2n-1、CnH2n-3，两个Ra独立地为H或两个Ra共同形成═O或═N—W3—R1；A为未取代或取代1至3个R的C6至C10芳香环，或由N、O和S中选择的1至5个杂原子中断的C2-C10杂芳环，或含有C═N并由N、O和S中选择的1至3个杂原子中断的4至7个成员的非芳杂环，其中一个未取代或取代1至3个R；Q为R，或者是未取代或取代1至3个R并由N、O和S中断的C6至C10芳香环或C2至C10杂芳环；R为C-连接的Rc或N-连接的RN。本发明的化合物可以调节AhR活性，可用于抑制癌细胞的生长，以及抑制肿瘤细胞的转移和侵袭。
• ARYL HYDROCARBON RECEPTOR MODULATORS
  申请人：SHENZHEN IMMUNOVA PHARMACEUTICAL CO., LTD.

  公开号：US20190330201A1

  公开（公告）日：2019-10-31

  The disclosure discloses an aryl hydrocarbon receptor modulators of formula (I), and pharmaceutically acceptable salts, R′ is H, CN, CH 2 (OH)R 0 , C m H 2m+1 , C n H 2n-1 , C n H 2n-3 , two R a is independently H, or two R a together form ═O or ═N—W 3 —R 1 ; A is a C 6 to C 10 aromatic ring, or a C 2 to C 10 heteroaromatic ring containing 1 to 5 heteroatom from N, O and S, or 4 to 7 membered non-aromatic heterocyclic ring containing 1 to 3 heteroatom from N, O and S and C═N, which are with no substituent or substituted by 1 or 3 R; Q is R, or a C 6 to C 10 aromatic ring or a C 2 to C 10 heteroaromatic ring containing 1 to 5 heteroatom selected from N, O and S, which are with no substituent or substituted by 1 or 3 R; R is R c connected with C or R N connected with N.
• An infrared study of rotational isomerism in thiazole-2-carboxylates
  作者：Perry T. Kaye、G. Denis Meakins、Charles Willbe、Peter R. Williams

  DOI：10.1039/p19810002335

  日期：——

  containing a range of substituents at the 4- and 5-positions has been prepared. Solutions of these esters (mostly new compounds) show well resolved doublets in the i.r. CO region which arise from rotational isomers. The higher wavenumber components are assigned to the more polar carbonyl O,S-anti-s-trans-rotamers and the lower wavenumber components to the carbonyl O,S-syn-s-trans-forms. Small, but systematic

  制备了一系列在4-和5-位含有一系列取代基的烷基噻唑-2-羧酸酯。这些酯的溶液（大多数是新化合物）在ir C O区域显示出良好拆分的双峰，这是由旋转异构体引起的。较高的波数分量被分配到更多的极性羰基Ø，小号-反-小号-反式-rotamers和下波数分量羰Ø，小号-顺式-小号-反式-forms。注意到甲酯之间的微小但系统的差异。